REPL net incomeQ2 2027-$57.12M
REPL net income was -$57.12M in fiscal Q2 2027 (ended Sep 30, 2026), compared with -$83.10M a year earlier. For the full fiscal 2026 it was -$313.94M, compared with -$247.30M in fiscal 2025.
Replimune Group Inc. (REPL) financials
For the twelve months ended Sep 30, 2026, Replimune Group Inc. reported -$271.03M of net income.
- Net income, TTM
- -$271.03M
- Free cash flow, TTM
- -$245.77M
- EPS, diluted, TTM
- -$2.79
- Cash
- $307.83M
- Total debt
- $99.77M
- Market cap
- $2.21B
FY2017FY2026
FY2017FY2026
REPL revenue and earnings growth
REPL EPSQ2 2027-$0.54
REPL diluted EPS was -$0.54 in fiscal Q2 2027 (ended Sep 30, 2026), compared with -$0.90 a year earlier. For the full fiscal 2026 it was -$3.38, compared with -$3.07 in fiscal 2025.
REPL free cash flowQ2 2027-$47.78M
REPL free cash flow was -$47.78M in fiscal Q2 2027 (ended Sep 30, 2026), compared with -$82.56M a year earlier. For the full fiscal 2026 it was -$284.57M, compared with -$198.94M in fiscal 2025.
Income statement
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $221.18M | $189.45M | $174.96M | $126.53M | $79.55M | $56.75M | $38.76M | $22.17M | $13.52M | $6.94M |
| Selling, general and admin | $98.73M | $72.18M | $59.81M | $50.55M | $38.77M | $23.20M | $17.44M | $8.77M | $5.71M | $2.71M |
| Operating income | -$319.92M | -$261.63M | -$234.77M | -$177.08M | -$118.31M | -$79.95M | -$56.20M | -$30.95M | -$19.23M | -$9.65M |
| Pre-tax income | -$314.49M | -$246.83M | -$215.39M | -$174.00M | -$118.04M | -$80.87M | -$52.63M | -$30.83M | -$19.70M | -$7.70M |
| Income tax | -$551.0K | $468.0K | $408.0K | $288.0K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$313.94M | -$247.30M | -$215.79M | -$174.28M | -$118.04M | -$80.87M | -$52.63M | -$30.83M | -$19.70M | -$7.70M |
| EPS, basic | -$3.38 | -$3.07 | -$3.24 | -$2.99 | -$2.26 | -$1.75 | -$1.54 | -$1.33 | -$3.96 | -$1.55 |
| EPS, diluted | -$3.38 | -$3.07 | -$3.24 | -$2.99 | -$2.26 | -$1.75 | -$1.54 | -$1.33 | -$3.96 | -$1.55 |
| Diluted shares | 92.8M | 80.6M | 66.6M | 58.2M | 52.2M | 46.2M | 34.3M | 23.2M | 5.0M | 5.0M |
Balance sheet
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $209.02M | $112.82M | $76.16M | $148.23M | $107.58M | $184.15M | $61.14M | $26.89M | $17.66M | $20.67M |
| Short-term investments | $59.87M | $372.69M | $346.21M | $436.80M | $289.71M | $293.78M | $109.06M | $109.11M | $43.97M | - |
| Inventory | $0 | - | - | - | - | - | - | - | - | - |
| Current assets | $279.12M | $495.88M | $433.67M | $592.60M | $403.98M | $483.75M | $174.25M | $140.98M | $64.70M | - |
| Total assets | $332.39M | $551.33M | $487.72M | $646.59M | $461.19M | $543.10M | $234.10M | $154.33M | $65.15M | - |
| Current liabilities | $58.23M | $62.36M | $40.44M | $33.83M | $20.76M | $14.55M | $11.87M | $9.88M | $5.16M | - |
| Long-term debt | $83.31M | $46.38M | $44.81M | $28.65M | $0 | - | - | - | - | - |
| Total debt | $83.31M | $46.38M | $44.81M | $28.65M | $0 | - | $9.80M | - | - | - |
| Total liabilities | $166.23M | $135.49M | $113.21M | $91.30M | $49.96M | $44.37M | $50.38M | $16.47M | $6.86M | - |
| Shareholders' equity | $166.16M | $415.84M | $374.51M | $555.29M | $411.23M | $498.73M | $183.72M | $137.86M | -$28.07M | -$11.52M |
Cash flow
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$280.34M | -$192.25M | -$185.47M | -$128.05M | -$82.18M | -$61.39M | -$60.55M | -$25.38M | -$16.01M | -$7.08M |
| Capital expenditures | $4.22M | $6.69M | $5.66M | $2.27M | $2.34M | $2.39M | $6.54M | $2.60M | $136.0K | $238.0K |
| Free cash flow | -$284.57M | -$198.94M | -$191.13M | -$130.32M | -$84.52M | -$63.78M | -$67.09M | -$27.98M | -$16.15M | -$7.32M |
| Investing cash flow | $310.84M | -$23.80M | $97.20M | -$142.50M | -$1.81M | -$188.78M | -$5.23M | -$65.94M | -$44.05M | -$238.0K |
| Financing cash flow | $66.29M | $252.40M | $16.28M | $311.30M | $6.60M | $372.46M | $100.17M | $101.39M | $54.75M | $15.00M |
| Stock-based compensation | $32.27M | $35.04M | $34.13M | $28.13M | $24.25M | $11.79M | $7.74M | $2.73M | $812.0K | $208.0K |
| Depreciation and amortization | $3.33M | $3.50M | $2.65M | $2.45M | $2.15M | $1.71M | $533.0K | $148.0K | $109.0K | $122.0K |
Key ratios
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on equity | -188.9% | -59.5% | -57.6% | -31.4% | -28.7% | -16.2% | -28.6% | -22.4% | - | - |
| Return on assets | -94.4% | -44.9% | -44.2% | -27.0% | -25.6% | -14.9% | -22.5% | -20.0% | -30.2% | - |
| Current ratio | 4.79 | 7.95 | 10.72 | 17.52 | 19.46 | 33.25 | 14.68 | 14.26 | 12.53 | - |
| Debt to equity | 0.50 | 0.11 | 0.12 | 0.05 | 0.00 | - | 0.05 | - | - | - |
Income statement
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $34.37M | $49.28M | $52.32M | $53.14M | $57.88M | $57.84M | $53.98M | $48.00M | $43.45M | $42.97M | $42.58M | $42.85M |
| Selling, general and admin | $21.92M | $18.97M | $21.01M | $18.73M | $26.41M | $32.58M | $25.35M | $18.02M | $15.47M | $14.39M | $16.18M | $13.69M |
| Operating income | -$56.28M | -$68.25M | -$73.34M | -$71.87M | -$84.29M | -$90.42M | -$79.33M | -$66.02M | -$58.92M | -$57.37M | -$58.76M | -$56.54M |
| Pre-tax income | - | - | -$73.46M | -$71.24M | - | - | -$74.24M | -$65.77M | -$53.05M | -$53.77M | -$55.14M | -$50.65M |
| Income tax | - | - | -$240.0K | -$311.0K | $0 | $0 | -$107.0K | $575.0K | $0 | $0 | -$65.0K | $473.0K |
| Net income | -$57.12M | -$69.77M | -$73.22M | -$70.93M | -$83.10M | -$86.69M | -$74.13M | -$66.34M | -$53.05M | -$53.77M | -$55.08M | -$51.12M |
| EPS, basic | -$0.54 | -$0.72 | -$0.76 | -$0.77 | -$0.90 | -$0.95 | -$0.82 | -$0.79 | -$0.68 | -$0.78 | -$0.82 | -$0.77 |
| EPS, diluted | -$0.54 | -$0.72 | -$0.76 | -$0.77 | -$0.90 | -$0.95 | -$0.82 | -$0.79 | -$0.68 | -$0.78 | -$0.82 | -$0.77 |
| Diluted shares | 105.2M | 96.9M | - | 92.2M | 91.9M | 91.5M | - | 83.5M | 78.6M | 69.2M | - | 66.6M |
Balance sheet
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $307.83M | $185.36M | $209.02M | $122.95M | $104.00M | $99.08M | $112.82M | $173.94M | $115.20M | $153.36M | $76.16M | $99.31M |
| Short-term investments | $0 | $9.97M | $59.87M | $146.19M | $221.35M | $305.97M | $372.69M | $364.29M | $318.56M | $317.47M | $346.21M | $368.68M |
| Inventory | $9.87M | - | $0 | - | - | - | - | - | - | - | - | - |
| Current assets | $324.04M | $200.81M | $279.12M | $280.35M | $333.75M | $413.37M | $495.88M | $547.58M | $442.63M | $480.32M | $433.67M | $479.16M |
| Total assets | $373.94M | $252.45M | $332.39M | $333.59M | $389.45M | $469.51M | $551.33M | $603.63M | $498.20M | $534.97M | $487.72M | $532.93M |
| Current liabilities | $45.55M | $38.41M | $58.23M | $50.09M | $52.90M | $59.56M | $62.36M | $47.89M | $43.79M | $35.68M | $40.44M | $38.65M |
| Long-term debt | $99.77M | $84.11M | $83.31M | $47.63M | $47.21M | $46.79M | $46.38M | $45.96M | $45.57M | $45.19M | $44.81M | - |
| Total debt | $99.77M | $84.11M | $83.31M | $47.63M | $47.21M | $46.79M | $46.38M | $45.96M | $45.57M | $45.19M | $44.81M | $44.43M |
| Total liabilities | $169.16M | $146.80M | $166.23M | $123.05M | $126.11M | $132.79M | $135.49M | $121.25M | $116.74M | $108.51M | $113.21M | $111.39M |
| Shareholders' equity | $204.78M | $105.64M | $166.16M | $210.54M | $263.34M | $336.71M | $415.84M | $482.37M | $381.46M | $426.45M | $374.51M | $421.54M |
Cash flow
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$47.70M | -$75.73M | -$56.16M | -$65.95M | -$81.21M | -$77.02M | -$53.73M | -$50.71M | -$38.64M | -$49.17M | -$46.17M | -$47.12M |
| Capital expenditures | $77.0K | $6.0K | $5.0K | $135.0K | $1.34M | $2.74M | $1.13M | $1.80M | $2.08M | $1.67M | $1.74M | $1.72M |
| Free cash flow | -$47.78M | -$75.73M | -$56.17M | -$66.09M | -$82.56M | -$79.76M | -$54.87M | -$52.51M | -$40.72M | -$50.84M | -$47.91M | -$48.84M |
| Investing cash flow | $9.76M | $49.99M | $86.51M | $75.12M | $84.17M | $65.05M | -$7.70M | -$46.32M | $458.0K | $29.77M | $23.20M | $53.96M |
| Financing cash flow | $160.55M | $800.0K | $55.68M | $10.45M | $324.0K | -$158.0K | -$132.0K | $155.93M | -$39.0K | $96.64M | -$130.0K | $14.87M |
| Stock-based compensation | $10.54M | $7.67M | $8.13M | $7.05M | $8.34M | $8.76M | $8.28M | $8.64M | $8.65M | $9.47M | $7.92M | $8.24M |
| Depreciation and amortization | $800.0K | $937.0K | $769.0K | $800.0K | $800.0K | $873.0K | $848.0K | $1.00M | $900.0K | $736.0K | $705.0K | $700.0K |
Key ratios
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current ratio | 7.11 | 5.23 | 4.79 | 5.60 | 6.31 | 6.94 | 7.95 | 11.43 | 10.11 | 13.46 | 10.72 | 12.40 |
| Debt to equity | 0.49 | 0.80 | 0.50 | 0.23 | 0.18 | 0.14 | 0.11 | 0.10 | 0.12 | 0.11 | 0.12 | 0.11 |
Source: XBRL data Replimune Group Inc. files with the SEC, latest filing dated Oct 28, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
REPL peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| REPL | - | - | -$271.03M | - | $2.21B |
| AMGN | $38.90B | +8.2% | $9.39B | 24.1% | $251.65B |
| GILD | $30.99B | +6.5% | -$3.86B | -12.5% | $211.94B |
| MRNA | $2.52B | +13.1% | -$2.79B | -110.5% | $101.49B |
| ARGX | $4.25B | +88.6% | $1.29B | 30.4% | $60.30B |
| RVMD | $0 | - | -$1.13B | - | $41.76B |
| BIIB | $10.30B | +2.3% | $347.50M | 3.4% | $37.44B |
| BNTX | €2.87B | +4.3% | -€1.14B | -39.6% | $21.91B |
| EXEL | $2.50B | +9.1% | $885.14M | 35.5% | $17.22B |
REPL FAQ
6 questionsIs REPL profitable?
No. Replimune Group Inc. reported a net loss of $271.03M for the twelve months ended Sep 30, 2026.How much cash and debt does REPL have?
Replimune Group Inc. reported $307.83M in cash and cash equivalents and $99.77M of debt on its most recent balance sheet in SEC filings.What is REPL free cash flow?
Replimune Group Inc. generated -$245.77M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of -$245.55M less capital expenditures.What is REPL earnings per share?
Diluted earnings per share were -$2.79 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.When did REPL last report financial results?
The latest statements here come from Replimune Group Inc.'s 10-Q filed on Oct 28, 2026, covering the period ended Sep 30, 2026.Where does this REPL financial data come from?
Quantisnow builds these statements from the structured XBRL data Replimune Group Inc. files with the SEC. It is provided for information only and is not investment advice.